Gut microbiome: New perspectives for type 2 diabetes prevention and treatment

doi:10.12998/wjcc.v11.i31.7508

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 31

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2875)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

104

WORD

HTML

1924

Figures (1-1)

210

Tables (1-1)

167

Sum=2430

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

113

Download

211

Sum=324

Nov 6, 2023 (publication date) through Jul 16, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Clin Cases. Nov 6, 2023; 11(31): 7508-7520
Published online Nov 6, 2023. doi: 10.12998/wjcc.v11.i31.7508

Full Size Figure Download Figure

Figure 1 Intestinal flora impacts the varied ways of metabolism in type 2 diabetes mellitus. GPCR: G-protein coupled receptor; TGR5: Takeda G protein-coupled receptor 5; FXR: Farnesoid X receptor.

Citation: Li SX, Guo Y. Gut microbiome: New perspectives for type 2 diabetes prevention and treatment. World J Clin Cases 2023; 11(31): 7508-7520
URL: https://www.wjgnet.com/2307-8960/full/v11/i31/7508.htm
DOI: https://dx.doi.org/10.12998/wjcc.v11.i31.7508